Wedelolactone 100 mg | 98.07%
TargetMol
Wedelolactone inhibits NF-κB-mediated gene transcription in cells by blocking the phosphorylation and degradation of IκBα.
More Information Supplier PageWedelolactone
Search Results
Wedelolactone 25 mg | 98.07%
TargetMol
Wedelolactone inhibits NF-κB-mediated gene transcription in cells by blocking the phosphorylation and degradation of IκBα.
More Information Supplier PageWedelolactone
Azathramycin 200 mg | Purity Not Available
TargetMol
Azithromycin A is an antibiotic derived from erythromycin, binding to the 50S subunit of the bacterial ribosome, and thus inhibits translation of mRNA.
More Information Supplier PageAzathramycin
Napabucasin 100 mg | 99.35%
TargetMol
Napabucasin is an orally available Stat3 and Y cell stemness inhibitor.
More Information Supplier PageNapabucasin
Orexin 2 Receptor Agonist 25 mg | 99.14%
TargetMol
Orexin 2 Receptor Agonist is an effective (EC50: 23 nM) and OX2R-selective (OX1R/OX2R EC50 ratio: 70) agonist.
More Information Supplier PageOrexin 2 Receptor Agonist
Orexin 2 Receptor Agonist 1 mg | 99.14%
TargetMol
Orexin 2 Receptor Agonist is an effective (EC50: 23 nM) and OX2R-selective (OX1R/OX2R EC50 ratio: 70) agonist.
More Information Supplier PageOrexin 2 Receptor Agonist
Abemaciclib 200 mg | 99.87%
TargetMol
LY2835219 is an effective and specific CDK4/6 inhibitor (IC50: 2/10 nM).
More Information Supplier PageAbemaciclib
Pomalidomide 200 mg | 98.40%
TargetMol
Pomalidomide inhibits TNF-α release in LPS stimulated human PBMCs (IC50: 13 nM). It is an anti-angiogenic agent and an immunomodulator.
More Information Supplier PagePomalidomide
Glycopyrrolate 25 mg | 99.86%
TargetMol
Glycopyrrolate is a muscarinic antagonist used as an antispasmodic, in some disorders of the gastrointestinal tract, and to reduce salivation with some anesthetics.
More Information Supplier PagePD 169316 100 mg | 98.83%
TargetMol
PD 169316 is a potent, cell-permeable and selective p38 MAP kinase inhibitor.
More Information Supplier PagePD 169316
